Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 3, 2026

Single-use solutions for PUPSIT: requirements, challenges, and solutions.

View Full Paper
Ask AI
Bookmark
Share

Authors

MGMartin GlenzPEPeter EiermannBMBritta Manser

Discussion

Loading...

Member takes

Overview

Review highlights requirements and solutions for implementing PUPSIT in biopharmaceutical manufacturing, indicating compliance risks.

Key Points

  • The aim is to analyze the implementation of PUPSIT in biopharmaceutical settings, focusing on regulatory requirements and practical challenges.
  • Review of regulatory requirements for PUPSIT in biopharmaceutical manufacturing.
  • Comparative analysis of manual, shadowboard-assisted, and automated PUPSIT systems.
  • Discussion of design strategies emphasizing simplicity and error-proofing.
  • Single-use systems can enhance compliance and minimize contamination risk through effective design.
  • Complexity in PUPSIT procedures increases potential contamination and human error risks.
  • Successful PUPSIT implementation requires a balance between compliance, operational efficiency, and environmental considerations.

Cite This Study

Glenz et al. (2026) studied this question.

synapsesocial.com/papers/69f6e5618071d4f1bdfc61bahttps://doi.org/10.1007/s00253-026-13847-5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Single-Use Systems between Compliance and Circularity: A Critical View under EU-GMP-Annex 1 and European Green Deal2026
  2. 2CQV Considerations for Single-Use Systems in Biopharmaceutical Manufacturing: A Practical Framework2026
  3. 3A Clean You Can Trust: Using an Evidence-Based Bundle to Transform Point-of-Use Treatment for Reusable Medical Devices at a Military Treatment Facility2024
  4. 4Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations2024
  5. 5Aseptic Process Challenges: The Threat of Underperforming Disinfectants for cGMP Applications2026